Docstoc

|| Aarkstore.com Latest Report || Orphan Diseases Therapeutics in Oncology to 2018 - Strongly

Document Sample
|| Aarkstore.com Latest Report || Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Orphan Diseases Therapeutics in Oncology to 2018 - Strongly
Diversified Developmental Pipelines Indicate Long-Term Growth
Potential despite Moderate Scope of Current Late Stage
Molecules


http://www.aarkstore.com/reports/Reportid-201971.html



RSS Link of GBI Research
http://www.aarkstore.com/feeds/GBI.xml



Summary

GBI Research, the leading business intelligence provider, has released its latest
research “Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified
Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate
Scope of Current Late Stage Molecules”, which provides insights into the Oncology
orphan disease therapeutics market until 2018. The report is built using data and
information sourced from proprietary databases, primary and secondary research
and in-house analysis by GBI Research’s team of industry experts. The report
provides an in-depth analysis of pancreatic cancer, ovarian cancer, multiple
myeloma, acute myeloid leukemia as well as Hodgkin lymphoma in the last seven
years as well as throughout the forecast period until 2018. The report examines the
global orphan diseases therapeutics in Oncology usage patterns.

Scope

- Data and analysis on the orphan diseases therapeutics in oncology market in the
leading geographies of the world – the US, the UK, Germany, France, Italy, Spain and
Japan.
- Annualized market data for the orphan diseases therapeutics in oncology market
from 2004 to 2010, with forecasts to 2018.
- Market data on the geographical landscape and therapeutic landscape, including
market size, annual cost of therapy, sales volume and treatment usage patterns such
as disease population, diagnosis population and prescription population.

Table of Contents :

1.1 List of Tables 7
1.2 List of Figures 9
2 Orphan Diseases Therapeutics in Oncology - Introduction 11
2.1 Introduction 11
2.2 Introduction to Cancer Etiology 11
2.3 Drug Classes and their Mechanisms of Action in the Treatment of Cancer 12
2.4 GBI Research Report Guidance 14
3 Orphan Diseases Therapeutics in Oncology - Market Overview 15
3.1 Revenues 15
3.2 Annual Cost of Therapy 16
3.3 Treatment Usage Pattern 17
3.3.1 Diseased Population 18
3.3.2 Diagnosed Population 18
3.3.3 Prescription Population 18
4 Orphan Diseases Therapeutics in Oncology - Geographical Landscape 19
4.1 Introduction 19
4.2 The US 19
4.2.1 Sales Revenues 19
4.2.2 ACT 21
4.2.3 Treatment Usage Patterns 22
4.3 Top Five Countries of Europe 24
4.3.1 Sales Revenues 24
4.3.2 ACT 26
4.3.3 Treatment Usage Patterns 27
4.4 Japan 29
4.4.1 Sales Revenues 29
4.4.2 ACT 30
4.4.3 Treatment Usage Patterns 31
5 Orphan Diseases Therapeutics in Oncology - Therapeutic Landscape 33
5.1 Pancreatic Cancer Therapeutics Market 33
5.1.1 Introduction 33
List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and
ACR16 to Provide Treatment Options and Boost the Huntington’s Disease Segment

Kidney and Renal Diseases Therapeutics Market to 2017 - Strong Pipeline and
Unmet Need Due to Poor Safety Profiles to Create Opportunities for Growth

The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to
2015, Competitive Benchmarking, Product Pipeline and Deals Analysis



Search More Reports Related to This Category :

http://www.aarkstore.com/search/viewresults.asp?search=Energy&PubId=&pagen
um=1




For More details Plz do contact :

Sonia

Phone:08149852585

Email: enquiry@aarkstore.com

Our Website :www.aarkstore.com

Facebook: http://www.facebook.com/aarkstore

Linkedin: http://in.linkedin.com/in/aarkstore

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:3
posted:5/10/2012
language:
pages:4
Description: GBI Research, the leading business intelligence provider, has released its latest research “Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules”, which provides insights into the Oncology orphan disease therapeutics market until 2018